Search

Search Constraints

You searched for: Author/Creator Podtelezhnikov, Alexei

Search Results

1. AhR Activation in Pharmaceutical Development: Applying Liver Gene Expression Biomarker Thresholds to Identify Doses Associated With Tumorigenic Risks in Rats. (25th May 2019)

2. Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain. Issue 1 (December 2016)

3. Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain. Issue 1 (December 2016)

4. Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain. Issue 1 (December 2016)

5. Qualification and application of an in vitro liver model early in pharmaceutical development to help derisk drug-induced liver injury (DILI). Issue 1 (January 2019)

6. The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease. Issue 1 (December 2017)

7. Transcriptomic biomarkers to assess the liver and metabolic responses associated with bioactivation mechanisms of drug induced liver injury. Issue 1 (January 2019)